@article{TCR28950,
author = {Cem Onal},
title = {Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?},
journal = {Translational Cancer Research},
volume = {8},
number = {7},
year = {2019},
keywords = {},
abstract = {Previously, local radiotherapy (RT) was only limited to palliate local symptoms, including bleeding or obstructive symptoms in metastatic prostate cancer patients. However, a population-based database and retrospective studies suggested that the local treatment of the prostate could improve survival in metastatic hormone-naïve prostate cancer with a small metastatic burden, ‘oligometastatic’ state (1-3). Recently two randomized trials demonstrated the efficacy of local RT to prostate in metastatic prostate cancer patients (4,5).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/28950}
}